American Journal of Neuroradiology, Vol 14, Issue 2 275-281, Copyright © 1993 by American Society of Neuroradiology
ARTICLES |
MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease
JC Chen, PA Hardy, W Kucharczyk, M Clauberg, JG Joshi, A Vourlas, M Dhar and RM Henkelman
Department of Radiology, University of Toronto, Ontario, Canada.
PURPOSE: To test the hypothesis that the T2 shortening observed on MR images of the brain in patients with Parkinson and Huntington diseases is due to tissue iron deposition. METHODS: Tissue iron and ferritin assays were performed on postmortem putamen and globus pallidus samples from subjects with Huntington and Parkinson disease. The assays were correlated with T2 measurements. Normal samples were included as controls. RESULTS: There were significant differences in T2 values, and iron and ferritin concentrations among the putamen samples. Compared with normal controls, subjects with Huntington disease had approximately a threefold increase in iron and a sixfold increase in ferritin concentrations; however, they also had the longest T2 values. Parkinson disease putamens had milder elevations of iron concentrations above that of controls (33%) and demonstrated slightly shorter T2 values. The globus pallidus samples demonstrated a similar trend in their T2s, iron, and ferritin levels, but there was a larger overlap in the T2 values. CONCLUSIONS: Our results indicate that tissue iron and ferritin concentrations are elevated in the brains of subjects with both Parkinson and Huntington disease but the elevated concentrations do not correlate with T2 shortening. Although iron and ferritin can shorten T2, we conclude that other factors must play a significant role in determining the T2 relaxation time and that iron or ferritin are not dominant in this regard.
This article has been cited by other articles:
![]() |
A. Goytain, R. M. Hines, and G. A. Quamme Huntingtin-interacting Proteins, HIP14 and HIP14L, Mediate Dual Functions, Palmitoyl Acyltransferase and Mg2+ Transport J. Biol. Chem., November 28, 2008; 283(48): 33365 - 33374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.L. Harder, K.M. Hopp, H. Ward, H. Neglio, J. Gitlin, and D. Kido Mineralization of the Deep Gray Matter with Age: A Retrospective Review with Susceptibility-Weighted MR Imaging AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lumsden, T. L. Henshall, S. Dayan, M. T. Lardelli, and R. I. Richards Huntingtin-deficient zebrafish exhibit defects in iron utilization and development Hum. Mol. Genet., August 15, 2007; 16(16): 1905 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dormont, K. G. Ricciardi, D. Tande, K. Parain, C. Menuel, D. Galanaud, S. Navarro, P. Cornu, Y. Agid, and J. Yelnik Is the Subthalamic Nucleus Hypointense on T2-Weighted Images? A Correlation Study Using MR Imaging and Stereotactic Atlas Data AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamada, R. G. Gonzalez, L. Ostergaard, S. Komili, R. M. Weisskoff, B. R. Rosen, W. J. Koroshetz, T. Nishimura, and A. G. Sorensen Iron-Induced Susceptibility Effect at the Globus Pallidus Causes Underestimation of Flow and Volume on Dynamic Susceptibility Contrast-Enhanced MR Perfusion Images AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 1022 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Georgiades, R. Itoh, X. Golay, P. C. M. van Zijl, and E. R. Melhem MR Imaging of the Human Brain at 1.5 T: Regional Variations in Transverse Relaxation Rates in the Cerebral Cortex AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1732 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF] |
||||
![]() |
J. M. Graham, M. N. J. Paley, R. A. Grunewald, N. Hoggard, and P. D. Griffiths Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence Brain, December 1, 2000; 123(12): 2423 - 2431. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirai, Y. Korogi, K. Yoshizumi, Y. Shigematsu, T. Sugahara, and M. Takahashi Limbic Lobe of the Human Brain: Evaluation with Turbo Fluid-attenuated Inversion-Recovery MR Imaging Radiology, May 1, 2000; 215(2): 470 - 475. [Abstract] [Full Text] |
||||
![]() |
G. Bartzokis, D. Sultzer, J. Cummings, L. E. Holt, D. B. Hance, V. W. Henderson, and J. Mintz In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging Arch Gen Psychiatry, January 1, 2000; 57(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Berg, G. Becker, B. Zeiler, O. Tucha, E. Hofmann, M. Preier, P. Benz, W. Jost, K. Reiners, and K. W. Lange Vulnerability of the nigrostriatal system as detected by transcranial ultrasound Neurology, September 1, 1999; 53(5): 1026 - 1026. [Abstract] [Full Text] |
||||
![]() |
G. Bartzokis, J. Cummings, S. Perlman, D. B. Hance, and J. Mintz Increased Basal Ganglia Iron Levels in Huntington Disease Arch Neurol, May 1, 1999; 56(5): 569 - 574. [Abstract] [Full Text] [PDF] |
||||








